Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy

NCT05811481 · clinicaltrials.gov ↗

UNKNOWN

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Transcatheter Arterial ChEmoembolization
Regorafenib

Interventions

PROCEDURE: TACE
DRUG: Regorafenib

Sponsor

WenBo Guo